Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Alefacept?

See the DrugPatentWatch profile for Alefacept

What is alefacept?

Alefacept (brand name Amevive) is an immunotherapy used for certain autoimmune diseases, most notably moderate-to-severe plaque psoriasis, by affecting immune cells involved in psoriasis.

What is alefacept used to treat?

Alefacept is used to treat moderate-to-severe chronic plaque psoriasis in people who are candidates for systemic therapy or phototherapy.

How does alefacept work?

Alefacept works by targeting immune-system interactions that drive psoriasis activity, helping reduce the activation and expansion of disease-relevant T cells.

How is alefacept given?

Alefacept is administered as injections under the skin (intramuscular use is not typical for this medication). The dosing schedule is structured and requires periodic monitoring.

What happens if alefacept isn’t effective?

If psoriasis does not improve adequately or the disease returns quickly, clinicians may adjust treatment timing or switch to another systemic option depending on prior response and patient factors.

What are common safety concerns with alefacept?

As an immunomodulating drug, alefacept can affect white blood cells and the immune system, so monitoring is important during treatment. Patients are typically evaluated for blood counts and infection risk during therapy.

Who should not take alefacept or who needs extra caution?

People with active infections or other conditions that make immunosuppression risky may need to avoid alefacept or use it only with specialist supervision and lab monitoring.

How long is a typical course, and what about maintenance?

Alefacept is usually given in defined treatment courses with breaks, and clinicians monitor response over time to decide whether additional courses are needed.

How does alefacept compare with other psoriasis biologics?

Compared with TNF inhibitors and newer biologics targeting specific inflammatory pathways, alefacept is an older mechanism focused on immune-cell interactions rather than directly blocking a single cytokine. Treatment choice depends on patient history, comorbidities, and response/side-effect priorities.

Is alefacept still available?

Availability depends on country and current approvals/market status. If you’re looking for current options, tell me your country and whether you’re asking for a prescription path or general information.

Sources

No sources were provided with your prompt, so I can’t cite any external material. If you share the source list or links you want used, I can produce a fully cited answer.